
Izberite svojo etiketo
prikazano neposredno na vialiLaboratorijsko poročilo
PDF- Testirano
- Semaglutide 10mg
- Laboratorij
- Analiza Białek
- Datum
- October 2026
- Rezultat
- 99% purity (10.30 mg measured)
- Endotoksini
- 5.83 EU/vial
- Št. naročila
- Geslo
Neodvisno testirano, preverljivo z geslom neposredno pri laboratoriju.
Semaglutide
GLP-1
- Laboratorijsko testirano · Čistost 99 %
- Odprema iz Nemčije
Naročilo
- DHL s sledenjem
- Diskretna embalaža
4.6 od 5 na Trustpilotu73 ocen
Iskano tudi kot: Semaglutid · Sema
Na prvi pogled
Semaglutide v številkah
Ključni podatki iz našega leksikona. Povlecite točko po krivulji in poglejte, koliko po izračunu ostane po enem odmerku.
Celoten vnos v leksikonuHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~7 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
~7days
- Class
- GLP-1 agonistsingle
- Frequency
- Once weeklysubcutaneous
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 50 mg6 sizes in the shop
What studies show
All 5 sources in the lexicon- ~15 %
Phase 3 study in obesity (STEP 1, ~15% weight reduction at 68 weeks) (opens in a new tab)
Wilding et al., New England Journal of Medicine, 2021 Cardiovascular study in obesity without diabetes (SELECT) (opens in a new tab)
Lincoff et al., New England Journal of Medicine, 2023Cardiovascular study in type 2 diabetes (SUSTAIN-6) (opens in a new tab)
Marso et al., New England Journal of Medicine, 2016
Znanje
Vse o Semaglutide
Podrobne informacije bodo kmalu na voljo.
Odmerjanje
Nalaganje podatkov o odmerjanju …
Priporočljivo zraven
Kaj potrebujete zraven
Bakteriostatska voda se samodejno doda v vašo košarico. Brizge in robčki z enim klikom.
Inzulinske brizge
10 kos. · 5.50 €
Alkoholni robčki
50 kos. · 10 €
Koliko vode?
Enote na brizgi za vašo velikost viale.
Odpri kalkulator →Is Semaglutide approved?
Yes. ChEMBL lists Semaglutide with phase 4 as the highest phase and a first approval in 2017. As an injection it is given once a week, there is also a tablet (separate entry). The information here describes the state of research and is not a recommendation for use.
How does Semaglutide differ from Tirzepatide and Retatrutide?
The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide also on GIP, Retatrutide additionally on the glucagon receptor. In return Semaglutide has the longest series of trials in the group, with large outcome trials on heart, kidney and liver.
What did the weight trials show?
In STEP 1 weight fell by 14.9 percent on average after 68 weeks, by 2.4 percent on placebo. Half of the participants lost at least 15 percent. In STEP 4 those who switched to placebo after 20 weeks regained weight: 6.9 percent by week 68, while the other group lost a further 7.9 percent.
What is known about heart, kidney and liver?
In SELECT (cardiovascular disease, overweight without diabetes) there were 6.5 versus 8.0 percent major cardiovascular events. In FLOW (type 2 diabetes with kidney disease) the risk of major kidney events was 24 percent lower. In ESSENCE MASH resolved after 72 weeks in 62.9 percent, in 34.3 percent on placebo.
How high were the doses in trials?
The highest study dose was 16 mg per week in a phase 2 trial in type 2 diabetes. Compared with the lowest dose there, blood sugar fell barely more, weight somewhat more, but there were more side effects and discontinuations. In STEP UP a higher dose also brought more weight loss and more complaints. The entry describes the opposite as a principle: start low and only increase until an effect is noticeable. This is not a dosing recommendation.
Which side effects were seen?
Most often nausea and diarrhoea, mostly transient and mild to moderate. In STEP 1 4.5 percent stopped because of gastrointestinal effects, 0.8 percent on placebo. In SUSTAIN-6 complications of the retina occurred more often in type 2 diabetes. With the higher dose from STEP UP altered skin sensations were more common.
How long does Semaglutide stay in the body?
According to the label the half-life is about one week, Semaglutide is still in the blood for about five weeks after the last dose. More than 99 percent is bound to the blood protein albumin. A steady level is reached after four to five weeks of weekly dosing.
Primerjave
Primerjava
Sorodno
Sorodni izdelki
Tirzepatide
Peptidi · GLP-1 in izguba maščobe GLP-1 in izguba maščobe
10 velikosti
Laboratorijsko testirano
= od 10 €/vialo
Retatrutide
Peptidi · GLP-1 in izguba maščobe GLP-1 in izguba maščobe
11 velikosti
Laboratorijsko testirano
= od 16 €/vialo
Mazdutide
Peptidi · GLP-1 in izguba maščobe GLP-1 in izguba maščobe
2 velikosti
= od 32 €/vialo
Survodutide
Peptidi · GLP-1 in izguba maščobe GLP-1 in izguba maščobe
1 velikost
= 60.8 €/vialo
Semaglutide

